Amneal Pharmaceuticals (AMRX) Intangibles (2017 - 2026)

Amneal Pharmaceuticals' Intangibles history runs 10 years deep, the most recent figure standing at $534.9 million for Q1 2026.

• In Q1 2026, Intangibles fell 22.39% year-over-year to $534.9 million; the TTM figure through Mar 2026 stood at $534.9 million (down 22.39% YoY), while the FY2025 annual figure was $563.5 million, down 23.06% from the prior year.
• Intangibles was $534.9 million for Q1 2026 at Amneal Pharmaceuticals, down from $563.5 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $1.2 billion in Q1 2022 to a low of $534.9 million in Q1 2026.
• Historically, Intangibles has averaged $872.3 million across 5 years, with a median of $859.3 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Intangibles slipped 4.21% in 2022, then fell 24.64% in 2025.
• A 5-year view of Intangibles shows it stood at $1.1 billion in 2022, then declined by 18.76% to $890.4 million in 2023, then decreased by 17.75% to $732.4 million in 2024, then dropped by 23.06% to $563.5 million in 2025, then declined by 5.08% to $534.9 million in 2026.
• The last three Intangibles figures came in at $534.9 million (Q1 2026), $563.5 million (Q4 2025), and $587.9 million (Q3 2025), per Business Quant data.